Inotiv Inc. (NOTV) NASDAQ
$5.42 (0.20) (-3.56%)
Market Cap: $144.94M
As of 04/17/24 04:00 PM EDT. Market closed.
Inotiv Inc. (NOTV)
NASDAQ
$5.42
(0.20) (-3.56%)
Market Cap: $144.94M
As of 04/17/24 04:00 PM EDT. Market closed.
*we are a cro and lab instrumentation provider* basi is a drug discovery and development services company with the energy and expertise to help you with your drug development project. we provide world-class research to the global pharmaceutical industry. our services include preclinical toxicology, early in vivo pk, bioanalysis and a full range of pharmaceutical analysis services. basi also ... read more
*we are a cro and lab instrumentation provider* basi is a drug discovery and development services company with the energy and expertise to help you with your drug development project. we provide world-class research to the global pharmaceutical industry. our services include preclinical toxicology, early in vivo pk, bioanalysis and a full range of pharmaceutical analysis services. basi also manufactures innovative scientific instruments including the culex® automated in vivo sampling system which can collect blood, bile, microdialysates, activity behavior, telemetry data and more from awake, freely-moving subjects. we are known for our scientific expertise, responsiveness to clients, exemplary regulatory record, and helping our clients meet key milestones on time. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Leasure Robert Jr. | President and CEO | Jun 07, 2019 | Buy | $1.98 | 7,500 | 14,864 | 105,000 | Jan 25, 2024, 04:19 PM |
Garrett Michael | Chief Commercial Officer | Dec 14, 2023 | Buy | $2.83 | 5,000 | 14,145 | 16,467 | Dec 15, 2023, 05:33 PM |
Beattie John Gregory | Chief Operating Officer | Dec 14, 2023 | Buy | $3.12 | 47,966 | 149,836 | 111,761 | Dec 15, 2023, 05:33 PM |
Sagartz John E | Chief Strategy Officer | Mar 14, 2023 | Buy | $4.91 | 5,100 | 25,041 | 692,047 | Mar 16, 2023, 04:03 PM |
Beattie John Gregory | Chief Operating Officer | Feb 22, 2023 | Buy | $6.99 | 5,000 | 34,950 | 63,795 | Feb 24, 2023, 04:02 PM |
Pitchford William D | Chief Human Resources Officer | Dec 09, 2022 | Sale | $5.82 | 2,123 | 12,366 | 74,051 | Dec 29, 2022, 07:12 AM |
Neff R Matthew | Director | Dec 01, 2022 | Sale | $6.12 | 1,000 | 6,120 | 62,388 | Dec 02, 2022, 08:11 PM |
Neff R Matthew | Director | Nov 01, 2022 | Sale | $21.12 | 1,000 | 21,123 | 63,888 | Nov 03, 2022, 04:13 PM |
Neff R Matthew | Director | Oct 17, 2022 | Sale | $19.10 | 1,000 | 19,100 | 64,388 | Oct 18, 2022, 05:37 PM |
Garrett Michael | Chief Commercial Officer | Sep 15, 2022 | Buy | $23.06 | 1,000 | 23,058 | 2,000 | Sep 19, 2022, 04:06 PM |
Beattie John Gregory | Chief Operating Officer | Sep 09, 2022 | Buy | $22.34 | 8,900 | 198,826 | 51,694 | Sep 13, 2022, 04:04 PM |
Harkness James | Chief Operating Officer, RMS | Mar 15, 2022 | Buy | $19.65 | 38,968 | 765,637 | 38,968 | Mar 16, 2022, 10:47 AM |
Downing Philip A | Sr. VP, Preclinical Srvcs. | Feb 22, 2022 | Buy | $23.97 | 2,000 | 47,946 | 42,195 | Feb 23, 2022, 05:22 PM |
Taylor Beth | VP- Finance & CFO | Feb 18, 2022 | Buy | $23.07 | 5,000 | 115,358 | 83,875 | Feb 22, 2022, 07:54 AM |
Davis Gregory Cole | Director | Feb 18, 2022 | Buy | $22.99 | 3,750 | 86,214 | 37,683 | Feb 22, 2022, 07:53 AM |
Davis Gregory Cole | Director | Feb 17, 2022 | Buy | $20.57 | 1,250 | 25,714 | 33,933 | Feb 22, 2022, 07:53 AM |
Garrett Michael | Chief Commercial Officer | Feb 18, 2022 | Buy | $23.50 | 1,000 | 23,500 | 1,000 | Feb 22, 2022, 07:52 AM |
Pitchford William D | Chief HR Officer | Feb 18, 2022 | Buy | $21.12 | 3,500 | 73,920 | 76,174 | Feb 18, 2022, 05:49 PM |
Beattie John Gregory | Chief Operating Officer | Feb 16, 2022 | Buy | $23.71 | 5,800 | 137,524 | 37,194 | Feb 18, 2022, 05:48 PM |
Beattie John Gregory | Chief Operating Officer | Feb 18, 2022 | Buy | $23.88 | 1,000 | 23,879 | 42,794 | Feb 18, 2022, 05:48 PM |
Beattie John Gregory | Chief Operating Officer | Feb 17, 2022 | Buy | $21.19 | 4,600 | 97,468 | 41,794 | Feb 18, 2022, 05:48 PM |
Leasure Robert Jr. | President and CEO | Feb 17, 2022 | Buy | $23.03 | 5,000 | 115,131 | 285,216 | Feb 17, 2022, 09:42 PM |
Sagartz John E | Chief Strategy Officer | Feb 17, 2022 | Buy | $19.95 | 2,506 | 49,999 | 681,030 | Feb 17, 2022, 05:18 PM |
Johnson Richard Allen | Director | Aug 02, 2021 | Option Exercise | $1.29 | 25,000 | 32,300 | 67,683 | Feb 07, 2022, 07:43 PM |
Downing Philip A | Sr. VP, Preclinical Srvcs. | Dec 22, 2021 | Sale | $43.04 | 3,057 | 131,577 | 40,195 | Jan 12, 2022, 04:31 PM |
Downing Philip A | Sr. VP, Preclinical Srvcs. | Dec 22, 2021 | Sale | $43.04 | 3,057 | 131,577 | 40,195 | Dec 30, 2021, 08:40 PM |
Sagartz John E | Chief Strategy Officer | May 28, 2021 | Buy | $24.78 | 2,012 | 49,857 | 646,782 | Jun 01, 2021, 04:01 PM |
Sagartz John E | Chief Strategy Officer | May 27, 2021 | Buy | $24.00 | 5 | 120 | 644,770 | Jun 01, 2021, 04:01 PM |
Taylor Beth | VP- Finance & CFO | Mar 05, 2021 | Buy | $17.70 | 5,000 | 88,500 | 34,295 | Mar 05, 2021, 04:41 PM |
Beattie John Gregory | Chief Operating Officer | Mar 01, 2021 | Buy | $18.60 | 1,712 | 31,843 | 25,000 | Mar 01, 2021, 04:14 PM |
Beattie John Gregory | Chief Operating Officer | Feb 23, 2021 | Buy | $14.00 | 8,288 | 116,032 | 23,288 | Feb 25, 2021, 04:03 PM |
Leasure Robert Jr. | President and CEO | Feb 24, 2021 | Buy | $14.42 | 5,000 | 72,100 | 5,000 | Feb 24, 2021, 04:29 PM |
Neff R Matthew | Director | Mar 13, 2020 | Buy | $3.93 | 3,350 | 13,166 | 43,430 | Jan 12, 2021, 04:41 PM |
Neff R Matthew | Director | Mar 12, 2020 | Buy | $3.80 | 8,497 | 32,289 | 40,080 | Jan 12, 2021, 04:41 PM |
Neff R Matthew | Director | Feb 20, 2020 | Buy | $4.60 | 9,458 | 43,507 | 31,583 | Jan 12, 2021, 04:34 PM |
Sagartz John E | Chief Strategy Officer | Aug 19, 2020 | Buy | $4.75 | 3,733 | 17,732 | 634,232 | Aug 20, 2020, 04:02 PM |
Neff R Matthew | Director | Aug 19, 2020 | Buy | $4.75 | 5,000 | 23,750 | 60,350 | Aug 19, 2020, 04:27 PM |
Leasure Robert Jr. | President and CEO | Jun 15, 2020 | Buy | $5.20 | 2,884 | 14,997 | 186,549 | Jun 16, 2020, 04:08 PM |
Pitchford William D | Chief HR Officer | May 21, 2020 | Buy | $4.47 | 10,000 | 44,700 | 32,000 | May 22, 2020, 04:02 PM |
Taylor Beth | VP- Finance & CFO | May 21, 2020 | Buy | $4.52 | 3,300 | 14,916 | 13,300 | May 21, 2020, 07:13 PM |
Taylor Beth | VP- Finance & CFO | May 20, 2020 | Buy | $4.42 | 4,933 | 21,804 | 10,000 | May 21, 2020, 07:13 PM |
Taylor Beth | VP- Finance & CFO | May 19, 2020 | Buy | $4.38 | 5,067 | 22,193 | 5,067 | May 21, 2020, 07:13 PM |
Leasure Robert Jr. | President and CEO | Mar 16, 2020 | Buy | $3.49 | 5,700 | 19,893 | 183,665 | Mar 17, 2020, 04:01 PM |
Neff R Matthew | Director | Mar 13, 2020 | Buy | $3.93 | 3,350 | 13,166 | 45,350 | Mar 16, 2020, 04:04 PM |
Neff R Matthew | Director | Mar 12, 2020 | Buy | $3.80 | 12,000 | 45,600 | 42,000 | Mar 16, 2020, 04:04 PM |
Neff R Matthew | Director | Feb 20, 2020 | Buy | $4.60 | 9,458 | 43,507 | 30,000 | Feb 21, 2020, 04:03 PM |
Johnson Richard Allen | Director | Feb 20, 2020 | Buy | $4.63 | 20,000 | 92,600 | 30,000 | Feb 20, 2020, 04:06 PM |
Leasure Robert Jr. | President and CEO | Sep 13, 2019 | Buy | $3.72 | 26,846 | 99,867 | 164,965 | Sep 16, 2019, 04:08 PM |
Oakley Daniel Thomas | Chief Operating Officer | Sep 13, 2019 | Buy | $3.65 | 1,000 | 3,650 | 48,546 | Sep 16, 2019, 04:08 PM |
Pitchford William D | Chief HR Officer | Sep 13, 2019 | Buy | $3.70 | 12,000 | 44,400 | 22,000 | Sep 16, 2019, 04:07 PM |
Perrow Wendy | Director | Sep 10, 2019 | Buy | $3.62 | 10,000 | 36,200 | 10,000 | Sep 11, 2019, 04:18 PM |
Oakley Daniel Thomas | Chief Operating Officer | Sep 05, 2019 | Buy | $3.45 | 10,500 | 36,225 | 45,546 | Sep 06, 2019, 04:01 PM |
Oakley Daniel Thomas | Chief Operating Officer | Sep 06, 2019 | Buy | $3.35 | 2,000 | 6,700 | 47,546 | Sep 06, 2019, 04:01 PM |
Leasure Robert Jr. | President and CEO | Sep 04, 2019 | Buy | $3.15 | 11,500 | 36,225 | 138,119 | Sep 05, 2019, 04:13 PM |
Oakley Daniel Thomas | Chief Operating Officer | Aug 29, 2019 | Buy | $2.69 | 5,000 | 13,450 | 36,046 | Sep 03, 2019, 04:21 PM |
Oakley Daniel Thomas | Chief Operating Officer | Aug 23, 2019 | Buy | $2.77 | 2,594 | 7,185 | 31,046 | Aug 26, 2019, 04:18 PM |
Leasure Robert Jr. | President and CEO | Aug 19, 2019 | Buy | $2.19 | 16,000 | 35,040 | 126,619 | Aug 20, 2019, 04:08 PM |
Neff R Matthew | Director | Jun 13, 2019 | Buy | $1.98 | 1,410 | 2,792 | 22,125 | Jun 14, 2019, 04:33 PM |
Leasure Robert Jr. | President and CEO | Jun 13, 2019 | Buy | $1.97 | 5,000 | 9,850 | 110,619 | Jun 14, 2019, 04:33 PM |
Leasure Robert Jr. | President and CEO | Jun 12, 2019 | Buy | $1.94 | 4 | 8 | 105,619 | Jun 14, 2019, 04:33 PM |
Oakley Daniel Thomas | Chief Operating Officer | Jun 14, 2019 | Buy | $1.99 | 7,500 | 14,925 | 28,452 | Jun 14, 2019, 04:32 PM |
Blumhoff Jill | VP, Finance & CFO | Jun 11, 2019 | Buy | $1.98 | 500 | 990 | 1,811 | Jun 13, 2019, 05:25 PM |
Downing Philip A | Sr. VP, Preclinical Srvcs. | Jun 10, 2019 | Buy | $1.96 | 5,000 | 9,800 | 25,765 | Jun 11, 2019, 04:04 PM |
Leasure Robert Jr. | President and CEO | Jun 07, 2019 | Buy | $1.96 | 5,000 | 9,800 | 105,615 | Jun 10, 2019, 05:00 PM |
Leasure Robert Jr. | President and CEO | Jun 06, 2019 | Buy | $1.95 | 1,000 | 1,950 | 100,615 | Jun 10, 2019, 05:00 PM |
Davis Gregory Cole | Director | May 31, 2019 | Buy | $2.00 | 5,000 | 10,000 | 20,000 | May 31, 2019, 04:02 PM |
Davis Gregory Cole | Director | May 30, 2019 | Buy | $1.96 | 5,000 | 9,800 | 15,000 | May 31, 2019, 04:02 PM |
Davis Gregory Cole | Director | May 29, 2019 | Buy | $1.99 | 5,000 | 9,950 | 10,000 | May 31, 2019, 04:02 PM |
Oakley Daniel Thomas | Chief Operating Officer | Mar 15, 2019 | Buy | $1.90 | 1 | 2 | 20,952 | Mar 19, 2019, 04:21 PM |
Sagartz John E | Director | Mar 14, 2019 | Buy | $1.94 | 1,400 | 2,716 | 3,900 | Mar 14, 2019, 04:16 PM |
Leasure Robert Jr. | President and CEO | Mar 12, 2019 | Buy | $1.94 | 6,000 | 11,640 | 99,615 | Mar 14, 2019, 04:08 PM |
Leasure Robert Jr. | President and CEO | Mar 08, 2019 | Buy | $1.77 | 4,000 | 7,080 | 93,615 | Mar 11, 2019, 04:10 PM |
Neff R Matthew | Director | Mar 08, 2019 | Buy | $1.75 | 5,715 | 10,001 | 20,715 | Mar 11, 2019, 04:09 PM |
Oakley Daniel Thomas | Chief Operating Officer | Mar 06, 2019 | Buy | $1.75 | 10,000 | 17,500 | 20,951 | Mar 07, 2019, 04:17 PM |
Oakley Daniel Thomas | Chief Operating Officer | Mar 01, 2019 | Buy | $1.54 | 125 | 192 | 10,951 | Mar 05, 2019, 04:34 PM |
Sagartz John E | Director | Feb 19, 2019 | Option Exercise | $1.43 | 2,500 | 3,575 | 2,500 | Mar 01, 2019, 05:16 PM |
Leasure Robert Jr. | President and CEO | Mar 01, 2019 | Buy | $1.62 | 10,000 | 16,200 | 89,615 | Mar 01, 2019, 05:12 PM |
Leasure Robert Jr. | President and CEO | Feb 28, 2019 | Buy | $1.51 | 8,900 | 13,439 | 79,615 | Mar 01, 2019, 05:12 PM |
Oakley Daniel Thomas | Chief Operating Officer | Feb 27, 2019 | Buy | $1.53 | 10,826 | 16,564 | 10,826 | Feb 28, 2019, 05:15 PM |
KISSINGER PETER | 10% Owner | Sep 14, 2018 | Buy | $1.74 | 10,000 | 17,382 | 1,033,457 | Sep 18, 2018, 09:50 PM |
Neff R Matthew | Director | Sep 12, 2018 | Option Exercise | $1.65 | 2,500 | 4,125 | 12,500 | Sep 18, 2018, 04:09 PM |
Neff R Matthew | Director | Sep 14, 2018 | Buy | $1.66 | 2,500 | 4,150 | 15,000 | Sep 18, 2018, 04:09 PM |
Blumhoff Jill | VP, Finance & CFO | Sep 13, 2018 | Option Exercise | $1.62 | 450 | 729 | 1,311 | Sep 18, 2018, 04:09 PM |
Downing Philip A | Sr. VP, Preclinical Srvcs. | Sep 11, 2018 | Buy | $1.67 | 5,000 | 8,350 | 20,765 | Sep 12, 2018, 12:00 AM |
Downing Philip A | Sr. VP, Preclinical Srvcs. | Feb 16, 2018 | Buy | $1.46 | 5,000 | 7,300 | 15,765 | Feb 20, 2018, 04:17 PM |
Neff R Matthew | Director | Sep 08, 2017 | Buy | $1.50 | 5,000 | 7,500 | 10,000 | Sep 08, 2017, 04:16 PM |
Davis Gregory Cole | Director | Aug 18, 2017 | Buy | $1.70 | 5,000 | 8,500 | 5,000 | Aug 23, 2017, 10:23 AM |
Neff R Matthew | Director | Aug 18, 2017 | Buy | $1.70 | 5,000 | 8,500 | 5,000 | Aug 23, 2017, 10:23 AM |
Blumhoff Jill | VP, Finance & CFO | Mar 15, 2017 | Option Exercise | $1.66 | 1,639 | 2,721 | 861 | Mar 17, 2017, 04:36 PM |
Blumhoff Jill | VP, Finance & CFO | Mar 15, 2017 | Option Exercise | $1.09 | 2,500 | 2,720 | 2,000 | Mar 17, 2017, 04:36 PM |
Downing Philip A | VP, Preclinical Srvcs. | Mar 01, 2017 | Option Exercise | $1.62 | 6,235 | 10,101 | 10,765 | Mar 15, 2017, 05:39 PM |
Downing Philip A | VP, Preclinical Srvcs. | Mar 01, 2017 | Option Exercise | $1.01 | 10,000 | 10,100 | 17,000 | Mar 15, 2017, 05:39 PM |
Dougherty Connie Leigh | VP, Business Development | May 27, 2016 | Buy | $0.92 | 423 | 389 | 9,074 | May 27, 2016, 04:05 PM |
Dougherty Connie Leigh | VP, Business Development | May 23, 2016 | Buy | $0.92 | 96 | 88 | 8,651 | May 25, 2016, 04:51 PM |
Dougherty Connie Leigh | VP, Business Development | May 19, 2016 | Buy | $0.92 | 1,655 | 1,523 | 8,555 | May 23, 2016, 04:29 PM |
Lemke Jacqueline M | President and CEO | Feb 29, 2016 | Buy | $1.17 | 6,000 | 7,020 | 9,000 | Mar 02, 2016, 05:04 PM |
Lemke Jacqueline M | President and CEO | Feb 29, 2016 | Buy | $1.19 | 4,000 | 4,742 | 60,685 | Mar 02, 2016, 05:04 PM |
Downing Philip A | VP, Preclinical Srvcs. | Sep 14, 2015 | Buy | $1.73 | 3,000 | 5,190 | 7,000 | Sep 16, 2015, 11:52 AM |
Dougherty Connie Leigh | VP, Business Development | Aug 21, 2015 | Buy | $1.42 | 6,900 | 9,798 | 6,900 | Aug 25, 2015, 05:20 PM |
Lemke Jacqueline M | President and CEO | Jun 18, 2015 | Option Exercise | $2.12 | 96,815 | 205,248 | 56,685 | Jun 22, 2015, 04:28 PM |
Lemke Jacqueline M | President and CEO | Jun 18, 2015 | Option Exercise | $1.38 | 125,500 | 173,200 | 153,500 | Jun 22, 2015, 04:28 PM |
Lemke Jacqueline M | President and CEO | Feb 27, 2015 | Buy | $2.04 | 3,000 | 6,120 | 3,000 | Mar 03, 2015, 06:30 PM |
Lemke Jacqueline M | President and CEO | Feb 27, 2015 | Buy | $2.04 | 7,000 | 14,280 | 28,000 | Mar 03, 2015, 06:30 PM |
Devine John P | VP--Toxicology | Aug 25, 2014 | Option Exercise | $1.01 | 2,500 | 2,525 | 2,500 | Aug 26, 2014, 04:17 PM |
Devine John P | VP--Toxicology | Jun 13, 2014 | Sale | $2.64 | 3,130 | 8,263 | 0 | Jun 19, 2014, 04:57 PM |
Devine John P | VP--Toxicology | Mar 03, 2014 | Option Exercise | $2.70 | 1,870 | 5,049 | 3,130 | Jun 17, 2014, 07:00 PM |
Devine John P | VP--Toxicology | Mar 03, 2014 | Option Exercise | $1.01 | 5,000 | 5,050 | 5,000 | Jun 17, 2014, 07:00 PM |
Devine John P | VP--Toxicology | Jun 13, 2014 | Sale | $2.64 | 3,130 | 8,263 | 0 | Jun 17, 2014, 07:00 PM |
Johnson Richard Allen | Director | Aug 17, 2012 | Buy | $1.26 | 10,000 | 12,600 | 10,000 | Aug 20, 2012, 06:07 PM |
Sullivan A. Charlene | Director | Aug 17, 2012 | Buy | $1.26 | 10,000 | 12,600 | 10,000 | Aug 20, 2012, 06:06 PM |
Lemke Jacqueline M | Intrm Pres & CEO, CFO & VP Fin | Aug 17, 2012 | Buy | $1.26 | 20,000 | 25,200 | 21,000 | Aug 20, 2012, 06:05 PM |
CRABB DAVID W | Director | Aug 17, 2012 | Buy | $1.26 | 10,000 | 12,600 | 11,300 | Aug 20, 2012, 06:04 PM |
Landis John B. | Director | Aug 17, 2012 | Buy | $1.26 | 30,000 | 37,800 | 30,000 | Aug 20, 2012, 06:03 PM |
Boulet Larry Steven | Director | Aug 17, 2012 | Buy | $1.26 | 11,500 | 14,490 | 15,000 | Aug 20, 2012, 06:02 PM |
OMACHINSKI DAVID L | Director | Aug 17, 2012 | Buy | $1.26 | 10,000 | 12,600 | 20,000 | Aug 20, 2012, 06:00 PM |
OMACHINSKI DAVID L | Director | Sep 15, 2010 | Buy | $0.90 | 10,000 | 9,000 | 10,000 | Sep 16, 2010, 05:00 PM |
Owner | Relationship | Date | Value($) |
Leasure Robert Jr. | President and CEO | 06/07/2019 | 14,864 |
Garrett Michael | Chief Commercial Officer | 12/14/2023 | 14,145 |
Beattie John Gregory | Chief Operating Officer | 12/14/2023 | 149,836 |
Sagartz John E | Chief Strategy Officer | 03/14/2023 | 25,041 |
Beattie John Gregory | Chief Operating Officer | 02/22/2023 | 34,950 |
Pitchford William D | Chief Human Resources Officer | 12/09/2022 | 12,366 |
Neff R Matthew | Director | 12/01/2022 | 6,120 |
Neff R Matthew | Director | 11/01/2022 | 21,123 |
Neff R Matthew | Director | 10/17/2022 | 19,100 |
Garrett Michael | Chief Commercial Officer | 09/15/2022 | 23,058 |
Beattie John Gregory | Chief Operating Officer | 09/09/2022 | 198,826 |
Harkness James | Chief Operating Officer, RMS | 03/15/2022 | 765,637 |
Downing Philip A | Sr. VP, Preclinical Srvcs. | 02/22/2022 | 47,946 |
Taylor Beth | VP- Finance & CFO | 02/18/2022 | 115,358 |
Davis Gregory Cole | Director | 02/18/2022 | 86,214 |
Davis Gregory Cole | Director | 02/17/2022 | 25,714 |
Garrett Michael | Chief Commercial Officer | 02/18/2022 | 23,500 |
Pitchford William D | Chief HR Officer | 02/18/2022 | 73,920 |
Beattie John Gregory | Chief Operating Officer | 02/16/2022 | 137,524 |
Beattie John Gregory | Chief Operating Officer | 02/18/2022 | 23,879 |
Beattie John Gregory | Chief Operating Officer | 02/17/2022 | 97,468 |
Leasure Robert Jr. | President and CEO | 02/17/2022 | 115,131 |
Sagartz John E | Chief Strategy Officer | 02/17/2022 | 49,999 |
Johnson Richard Allen | Director | 08/02/2021 | 32,300 |
Downing Philip A | Sr. VP, Preclinical Srvcs. | 12/22/2021 | 131,577 |
Downing Philip A | Sr. VP, Preclinical Srvcs. | 12/22/2021 | 131,577 |
Sagartz John E | Chief Strategy Officer | 05/28/2021 | 49,857 |
Sagartz John E | Chief Strategy Officer | 05/27/2021 | 120 |
Taylor Beth | VP- Finance & CFO | 03/05/2021 | 88,500 |
Beattie John Gregory | Chief Operating Officer | 03/01/2021 | 31,843 |
Beattie John Gregory | Chief Operating Officer | 02/23/2021 | 116,032 |
Leasure Robert Jr. | President and CEO | 02/24/2021 | 72,100 |
Neff R Matthew | Director | 03/13/2020 | 13,166 |
Neff R Matthew | Director | 03/12/2020 | 32,289 |
Neff R Matthew | Director | 02/20/2020 | 43,507 |
Sagartz John E | Chief Strategy Officer | 08/19/2020 | 17,732 |
Neff R Matthew | Director | 08/19/2020 | 23,750 |
Leasure Robert Jr. | President and CEO | 06/15/2020 | 14,997 |
Pitchford William D | Chief HR Officer | 05/21/2020 | 44,700 |
Taylor Beth | VP- Finance & CFO | 05/21/2020 | 14,916 |
Taylor Beth | VP- Finance & CFO | 05/20/2020 | 21,804 |
Taylor Beth | VP- Finance & CFO | 05/19/2020 | 22,193 |
Leasure Robert Jr. | President and CEO | 03/16/2020 | 19,893 |
Neff R Matthew | Director | 03/13/2020 | 13,166 |
Neff R Matthew | Director | 03/12/2020 | 45,600 |
Neff R Matthew | Director | 02/20/2020 | 43,507 |
Johnson Richard Allen | Director | 02/20/2020 | 92,600 |
Leasure Robert Jr. | President and CEO | 09/13/2019 | 99,867 |
Oakley Daniel Thomas | Chief Operating Officer | 09/13/2019 | 3,650 |
Pitchford William D | Chief HR Officer | 09/13/2019 | 44,400 |
Perrow Wendy | Director | 09/10/2019 | 36,200 |
Oakley Daniel Thomas | Chief Operating Officer | 09/05/2019 | 36,225 |
Oakley Daniel Thomas | Chief Operating Officer | 09/06/2019 | 6,700 |
Leasure Robert Jr. | President and CEO | 09/04/2019 | 36,225 |
Oakley Daniel Thomas | Chief Operating Officer | 08/29/2019 | 13,450 |
Oakley Daniel Thomas | Chief Operating Officer | 08/23/2019 | 7,185 |
Leasure Robert Jr. | President and CEO | 08/19/2019 | 35,040 |
Neff R Matthew | Director | 06/13/2019 | 2,792 |
Leasure Robert Jr. | President and CEO | 06/13/2019 | 9,850 |
Leasure Robert Jr. | President and CEO | 06/12/2019 | 8 |
Oakley Daniel Thomas | Chief Operating Officer | 06/14/2019 | 14,925 |
Blumhoff Jill | VP, Finance & CFO | 06/11/2019 | 990 |
Downing Philip A | Sr. VP, Preclinical Srvcs. | 06/10/2019 | 9,800 |
Leasure Robert Jr. | President and CEO | 06/07/2019 | 9,800 |
Leasure Robert Jr. | President and CEO | 06/06/2019 | 1,950 |
Davis Gregory Cole | Director | 05/31/2019 | 10,000 |
Davis Gregory Cole | Director | 05/30/2019 | 9,800 |
Davis Gregory Cole | Director | 05/29/2019 | 9,950 |
Oakley Daniel Thomas | Chief Operating Officer | 03/15/2019 | 2 |
Sagartz John E | Director | 03/14/2019 | 2,716 |
Leasure Robert Jr. | President and CEO | 03/12/2019 | 11,640 |
Leasure Robert Jr. | President and CEO | 03/08/2019 | 7,080 |
Neff R Matthew | Director | 03/08/2019 | 10,001 |
Oakley Daniel Thomas | Chief Operating Officer | 03/06/2019 | 17,500 |
Oakley Daniel Thomas | Chief Operating Officer | 03/01/2019 | 192 |
Sagartz John E | Director | 02/19/2019 | 3,575 |
Leasure Robert Jr. | President and CEO | 03/01/2019 | 16,200 |
Leasure Robert Jr. | President and CEO | 02/28/2019 | 13,439 |
Oakley Daniel Thomas | Chief Operating Officer | 02/27/2019 | 16,564 |
KISSINGER PETER | 10% Owner | 09/14/2018 | 17,382 |
Neff R Matthew | Director | 09/12/2018 | 4,125 |
Neff R Matthew | Director | 09/14/2018 | 4,150 |
Blumhoff Jill | VP, Finance & CFO | 09/13/2018 | 729 |
Downing Philip A | Sr. VP, Preclinical Srvcs. | 09/11/2018 | 8,350 |
Downing Philip A | Sr. VP, Preclinical Srvcs. | 02/16/2018 | 7,300 |
Neff R Matthew | Director | 09/08/2017 | 7,500 |
Davis Gregory Cole | Director | 08/18/2017 | 8,500 |
Neff R Matthew | Director | 08/18/2017 | 8,500 |
Blumhoff Jill | VP, Finance & CFO | 03/15/2017 | 2,721 |
Blumhoff Jill | VP, Finance & CFO | 03/15/2017 | 2,720 |
Downing Philip A | VP, Preclinical Srvcs. | 03/01/2017 | 10,101 |
Downing Philip A | VP, Preclinical Srvcs. | 03/01/2017 | 10,100 |
Dougherty Connie Leigh | VP, Business Development | 05/27/2016 | 389 |
Dougherty Connie Leigh | VP, Business Development | 05/23/2016 | 88 |
Dougherty Connie Leigh | VP, Business Development | 05/19/2016 | 1,523 |
Lemke Jacqueline M | President and CEO | 02/29/2016 | 7,020 |
Lemke Jacqueline M | President and CEO | 02/29/2016 | 4,742 |
Downing Philip A | VP, Preclinical Srvcs. | 09/14/2015 | 5,190 |
Dougherty Connie Leigh | VP, Business Development | 08/21/2015 | 9,798 |
Lemke Jacqueline M | President and CEO | 06/18/2015 | 205,248 |
Lemke Jacqueline M | President and CEO | 06/18/2015 | 173,200 |
Lemke Jacqueline M | President and CEO | 02/27/2015 | 6,120 |
Lemke Jacqueline M | President and CEO | 02/27/2015 | 14,280 |
Devine John P | VP--Toxicology | 08/25/2014 | 2,525 |
Devine John P | VP--Toxicology | 06/13/2014 | 8,263 |
Devine John P | VP--Toxicology | 03/03/2014 | 5,049 |
Devine John P | VP--Toxicology | 03/03/2014 | 5,050 |
Devine John P | VP--Toxicology | 06/13/2014 | 8,263 |
Johnson Richard Allen | Director | 08/17/2012 | 12,600 |
Sullivan A. Charlene | Director | 08/17/2012 | 12,600 |
Lemke Jacqueline M | Intrm Pres & CEO, CFO & VP Fin | 08/17/2012 | 25,200 |
CRABB DAVID W | Director | 08/17/2012 | 12,600 |
Landis John B. | Director | 08/17/2012 | 37,800 |
Boulet Larry Steven | Director | 08/17/2012 | 14,490 |
OMACHINSKI DAVID L | Director | 08/17/2012 | 12,600 |
OMACHINSKI DAVID L | Director | 09/15/2010 | 9,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BALYASNY ASSET MANAGEMENT L.P. | 975,295 | 0.00672% | -18.49% | Event Driven |
BLACKROCK INC. | 216,137 | 0.00002% | No change | Other |
GEODE CAPITAL MANAGEMENT, LLC | 192,297 | 0.00007% | 4.09% | Other |
AQR CAPITAL MANAGEMENT LLC | 144,168 | 0.001% | -64.56% | Other |
RENAISSANCE TECHNOLOGIES LLC | 47,464 | 0.00027% | -13.01% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View